Wellington Management Group
TXMD icon

Wellington Management Group’s TherapeuticsMD TXMD Stock Holding History

Wellington Management Group’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-115,729
Closed -$33.4M – 2316
2016
Q4 		$33.4M Sell
115,729
-156,439
-57% -$48.5M 0.01% 840
2016
Q3 		$92.7M Sell
272,168
-202,639
-43% -$74M 0.02% 518
2016
Q2 		$202M Sell
474,807
-63,513
-12% -$26.2M 0.05% 310
2016
Q1 		$172M Buy
538,320
+40,348
+8% +$13.8M 0.05% 344
2015
Q4 		$258M Buy
497,972
+970
+0.2% +$358K 0.07% 260
2015
Q3 		$146M Buy
497,002
+13,565
+3% +$4.82M 0.04% 352
2015
Q2 		$190M Buy
483,437
+2,633
+0.5% +$929K 0.05% 327
2015
Q1 		$145M Buy
480,804
+43,732
+10% +$10.7M 0.04% 409
2014
Q4 		$97.2M Buy
437,072
+830
+0.2% +$171K 0.03% 519
2014
Q3 		$101M Buy
436,242
+29,011
+7% +$7.31M 0.03% 499
2014
Q2 		$90M Buy
407,231
+1,243
+0.3% +$277K 0.02% 555
2014
Q1 		$128M Buy
405,988
+92
+0% +$29.3K 0.04% 460
2013
Q4 		$106M Hold
405,896
– – 0.03% 510
2013
Q3 		$59.5M Buy
405,896
+44,149
+12% +$5.34M 0.02% 660
2013
Q2 		$54.8M Buy
+361,747
New +$49.6M 0.02% 663

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Wellington Management Group's TXMD Position: Q1 2017 in Review

Wellington Management Group sold out of TherapeuticsMD (TXMD) in Q1 2017, closing a stake of 115,729 shares — an estimated $33.4M sold.

Wellington Management Group first reported a position in TXMD in Q2 2013 and held it in 15 quarters. The position peaked at $258M in Q4 2015. 138 funds tracked by Wall St. Rank hold TXMD as of Q1 2017.

  • Wellington Management Group reported no remaining TherapeuticsMD position as of Q1 2017 after selling out during the quarter.
  • Wellington Management Group sold 115,729 TherapeuticsMD shares in Q1 2017, an estimated $33.4M.
  • Wellington Management Group first reported a position in TherapeuticsMD in Q2 2013 and held it in 15 quarters.
  • Wellington Management Group's TherapeuticsMD position peaked at $258M in Q4 2015.
  • 138 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.